Loading...
XMU-MP-1 induces growth arrest in a model human mini-organ and antagonises cell cycle-dependent paclitaxel cytotoxicity
Mitchell, Ellen ; Mellor, Charlotte E. L. ; Purba, Talveen S.; orcid: 0000-0003-3735-7735; email: talveen.purba@manchester.ac.uk
Mitchell, Ellen
Mellor, Charlotte E. L.
Purba, Talveen S.; orcid: 0000-0003-3735-7735; email: talveen.purba@manchester.ac.uk
Advisors
Editors
Other Contributors
Affiliation
EPub Date
Publication Date
2020-09-17
Submitted Date
2020-05-22
Collections
Other Titles
Abstract
Abstract: Background: XMU-MP-1 is an inhibitor of the Hippo pathway kinases MST1/2 and has been shown to promote the downstream activation of the pro-proliferative, pro-regenerative and anti-apoptotic transcriptional regulator YAP1. We tested whether XMU-MP-1 can activate YAP1 in a model human mini-organ, namely the hair follicle, to determine whether it can be pharmacologically exploited to promote regeneration in the hair follicle as a novel strategy to treat pathological hair loss disorders. Results: XMU-MP-1 treatment inhibited MOB1 phosphorylation but did not increase active YAP1 in the hair follicle. Rather than promote proliferation, XMU-MP-1 serendipitously decreased the number of Ki-67+, EdU+ and phospho histone H3+ hair matrix keratinocytes and antagonised the cytotoxic effects of paclitaxel. Conclusions: XMU-MP-1 perturbs epithelial cell cycle progression in a model human mini-organ. This may arise as an off-target effect, especially when XMU-MP-1 has been described to strongly inhibit 21 additional kinases beyond MST1/2. Therefore, whilst these effects may be dependent on tissue context, researchers should exercise caution when interpreting the effects of XMU-MP-1, especially in tissues with actively proliferating cell populations.
Citation
Cell Division, volume 15, issue 1, page 11
Publisher
BioMed Central
Journal
Research Unit
DOI
PubMed ID
PubMed Central ID
Type
article
Language
Description
From Springer Nature via Jisc Publications Router
History: received 2020-05-22, registration 2020-09-03, accepted 2020-09-03, pub-electronic 2020-09-17, online 2020-09-17, collection 2020-12
Publication status: Published
Funder: Manchester Biomedical Research Centre; doi: http://dx.doi.org/10.13039/100014653
History: received 2020-05-22, registration 2020-09-03, accepted 2020-09-03, pub-electronic 2020-09-17, online 2020-09-17, collection 2020-12
Publication status: Published
Funder: Manchester Biomedical Research Centre; doi: http://dx.doi.org/10.13039/100014653
